Roche has introduced two high-performance DNA transfection reagents for its cellular analysis portfolio for life science research.
Designed for commonly used and hard-to-transfect cell lines, the X-tremegene 9 and X-tremegene HP reagents offer high efficiency, reproducibility and cell survival rates to deliver more viable cells and help accelerate research efforts, said the company.
Both reagents support a wide variety of cellular and molecular research applications, such as gene expression analysis and protein production.
The X-tremegene 9 reagent offers efficient performance across a wide variety of commonly used cell lines, while Roche's X-tremegene HP reagent is suitable for cell lines that are difficult to transfect or not easily transfected with other reagents.
Both reagents combine low cytotoxicity with high efficiency and reproducibility, providing more viable cells with more physiologically relevant results.
They also offer easy-to-implement protocols: researchers simply dilute the reagent, incubate it with plasmid DNA, then pipette it directly onto cells.
Both reagents function well in the presence or absence of serum and remain stable after repeated vial openings.
